Bristol-Myers Squibb Company
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS
Last updated:
Abstract:
The present invention is directed to compounds of the formula ##STR00001## wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Status:
Application
Type:
Utility
Filling date:
30 Aug 2018
Issue date:
27 Aug 2020